Lincoln Pharmaceuticals Limited (LINCOLN.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Lincoln Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1687
First IPO Date
December 17, 2015
Key Executives
| Name | Title | Pay | Year Born |
| Mahendrabhai Gulabdas Patel | MD & Whole Time Director | 5.06M | 1954 |
| Ashish Rajnikant Patel | Whole Time Director | 6.85M | 1981 |
| Hashmukhbhai Ishwarlal Patel | Whole Time Director | 6.85M | 1958 |
| Munjal Mahendrabhai Patel | Whole Time Director | 6.85M | 1982 |
| Darshit Ashvinkumar Shah | Chief Financial Officer | 0 | N/A |
| Laxmikant Harsola | Vice President of Technical | 0 | N/A |
| Trusha Shah | Company Secretary & Compliance Officer | 0 | N/A |
| Amit Dwivedi B-PHARM | Group Marketing Manager | 0 | 1976 |
| Sanjay Bhatt | Senior Manager of Operation | 0 | N/A |
| Sanjiv Patel | Senior Manager of Planning & Administration | 0 | N/A |
Description
Lincoln Pharmaceuticals Limited, established in 1979 and headquartered in Ahmedabad, India, is a pharmaceutical company engaged in the manufacturing and global distribution of its products. Its comprehensive product line addresses a wide array of medical needs, including dermatological, gynecological, gastrointestinal, and otological conditions. The company also specializes in phosphodiesterase type 5 inhibitors and general anesthetics. Further expanding its therapeutic reach, Lincoln provides treatments for common ailments like coughs, colds, and allergies, alongside anti-asthmatics. Other key product categories include sterile ophthalmic solutions (eye drops and ointments), anti-malarial drugs, and a range of vitamins, minerals, and antioxidants. The portfolio is further diversified with anti-bacterial, anti-viral, and anti-fungal agents; pain relief and fever reduction medications (analgesics and anti-pyretics); and specialized drugs for mental health (anti-psychotics, anti-convulsants, anti-depressants) and diabetes (anti-diabetics). Cardiovascular health is addressed with anti-hypertensives and diuretics, while gastrointestinal issues are targeted with anti-diarrheals, anti-spasmodics, and laxatives. Additionally, the company offers branded generic pharmaceuticals.